Search results
Research identifies an infectious language epidemic
Digital Journal· 4 days agoWhat effects did social media rhetoric have on COVID-19 infection and death rates across the U.S., and what can policymakers and public health officials...
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 5 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
What to know about the new 'FLiRT' COVID variants
Fox News· 6 days agoAccording to the World Health Organization, the "FLiRT" variants of the SARS-CoV-2 coronavirus have been the dominant forms of the virus circulating...
Explainer-What are the FLiRT COVID variants and are they more contagious? By Reuters
Investing.com· 6 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
The Heroes Of Vaccine Development: Lipid Nanoparticles
BioresearchOnline· 4 days agoLipid nanoparticles (LNPs) have played a crucial role in the advancement of vaccine development,...
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 4 days agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells | Cornell Chronicle
Cornell News Service· 2 days agoAn interdisciplinary collaboration has designed a way to “cloak” proteins so that they can be...
mRNA Vaccines vs. the Pandemic
The North Coast Journal· 7 days ago"I knew that [mRNA] can be used for everything and I had a kind of a Cassandra feeling, that I can see the future and nobody believes me." About 13...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US By Reuters
Investing.com· 5 days agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European...
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology...
Benzinga· 2 days agoPlanegg/Martinsried, May 28, 2024 – Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid